Publication Information
Available Issues

Liver International


Featured in This Issue:
Prognostic System for Liver Cirrhosis: Model for End-Stage Liver Disease... Decision Analysis Study of Liver Biopsy Value in Steatohepatitis... Lamivudine Monotherapy in Chronic Hepatitis B: Genotypic Evidence... Usefulness of Surveillance for Diagnosis of Hepatocellular Carcinoma...


Available Content
2008
DOTS
Prognostic System for Liver Cirrhosis: Model for End-Stage Liver Disease... Decision Analysis Study of Liver Biopsy Value in Steatohepatitis... Lamivudine Monotherapy in Chronic Hepatitis B: Genotypic Evidence... Usefulness of Surveillance for Diagnosis of Hepatocellular Carcinoma...
DOTS

Celiac Disease Autoantibodies in Autoimmune Liver Disease and Transplant... Chronic Hepatitis B vs Hepatitis C Treatment With Peginterferon Alpha-2a... Aspartate Aminotransferase for Predicting Liver Fibrosis in HIV/Hep C... Budd-Chiari Syndrome: Illustrated Review of Current Management...
DOTS

Asymptomatic at Genetic Risk of Haemochromatosis Prevent Iron Overload ... Delayed Hepatocellular Carcinoma and HCV-Related Chronic Liver Disease... Hepatitis B Viral Replication Affects Hepatocellular Carcinoma Recurrence... Prevalence of Diabetes Mellitus and IR in Patients With Chronic Hepatitis...
DOTS

Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis... Transjugular Intrahepatic Portosystemic Shunts in LT Recipients... High Hepatitis C Viral Load is Associated With IR in Hep C Patients... Radiological Diagnosis of Hepatocellular Carcinoma...
DOTS

Prophylaxsis Against Recurrance of HBV After LT: Retrospective Analysis... High Incidence of Type 1 DM During or Shortly After Treatment for HCV... Lamivudine Prophylaxis Is Effective in Reducing HBV Mortality in Chemo... Successful Management of Chylous Ascites After LDLT With Somatostatin...
DOTS

2007
DOTS
Managing Chronic Hepatitis C in the Difficult-To-Treat Patient... Changes in Serum Hepatitis B e Antigen (HBeAg) Levels ... Prevalence of Hepatic Iron Overload and Association With HCC in LD... Doppler US - Prediction of Severe Portal Hypertension in Hep C CLD...
DOTS

Interferon and Lamivudine vs. Interferon for Hepatitis B e Antigen-Positive... Antimitochondrial Antibodies of Immunoglobulin G3 Subclass - PBC... Percutaneous Liver Biopsy in Clinical Practice... Treating Nonalcoholic Fatty Liver Disease...
DOTS

Development of Autoimmune Hepatitis in Primary Biliary Cirrhosis... Psychiatric Side Effects During Pegylated Interferon- Alpha Retreatment... Damping Index of Doppler Hepatic Vein Waveform - Portal Hypertension... Health-Related Quality of Life in Patients With Chronic Hepatitis B...
DOTS

Hepatitis B Vaccination After Living Donor Liver Transplantation... Coronary Atherosclerotic Disease With Liver Transaminase Levels... Relapse to Prior Therapy - Most Important Factor for Retreatment Response... Noninvasive Models to Predict Liver Cirrhosis - Patients With Chronic Hep B...
DOTS

Severe Portal Hypertension Secondary to Arterio-portal Fistula... Clinical Significance of Core Promoter and Precore Mutations in HBeAg-HBV... Mild Donor Liver Steatosis Has No Impact on Hepatitis C Virus Fibrosis ... Hepatic Steatosis by Ultrasound in Chronic Hepatitis C Virus Infection ...
DOTS

Outcome of Recurrent Hepatitis C Based on Viral Load 1 Week Post Transplant... Hepatic Steatosis Correlates With the Postoperative Recurrence of HCV HCC... Profound Suppression of HCV Following Superinfection With HBV... Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B...
DOTS

Consequences of Treatment Withdrawal in Type 1 Autoimmune Hepatitis... Tacrolimus for the Treatment of Primary Sclerosing Cholangitis... A Novel Therapeutic Drug (Copper Nicotinic Acid Complex) for NAFLD... Current Concepts in the Pathogenesis of Nonalcoholic Fatty Liver Disease...
DOTS

MELD Score - Predict Outcome - Non-Acetaminophen-Induced ALF Patients... Progression to Cirrhosis in Hepatitis C Patients: An Age-dependent Process... Treating Hepatitis C in African Americans... Therapeutic Management of Recurrent HCV After Liver Transplantation...
DOTS

Older Donor Allografts - Poor Survival After Living Donor Liver Transplant... Open-label Pilot Study of Folic Acid in Patients With NASH... New Molecular Targets for HCC: The ErbB1 Signaling System... Dynamics of HBeAg Index Ratio Correlate With Treatment Response...
DOTS

Recurrence of PSC After Living Donor Liver Transplantation... Prevalence and Clinical Associations of Posttransplant Fatty Liver Disease... Impact of HIV Infection in Patients Infected With HCV... Efficacy of Adefovir Treatment of Lamivudine-Resistant HBV Genotype C...
DOTS

2006
DOTS
High-Dose Interferon-Alfa Plus Ribavirin for Chronic Hepatitis C Patients... Intracellular Survival Pathways in the Liver... Spontaneous Retroperitoneal and Rectus Muscle Hemorrhage ... Serum Aminotransferases in Clinical Trials of NASH...
DOTS

Impact of Liver Steatosis on the Antiviral Response in HCV... Anemia Associated With Antiviral Therapy in Chronic Hepatitis C... Noninvasive Serum Markers for Structural Liver Damage in HCV... Alcoholic Liver Disease vs NAFLD...
DOTS

Distinguishing NAFLD Mild Steatosis From Cryptogenic Chronic Hepatitis ... Viral Factors Correlate With HBeAg Seroconverson in Chronic Hepatitis B... Comparison of 11C-acetate PET and 67Gallium Citrate Scintigraphy in HCC... Incretin Mimetics as a Novel Therapeutic Option for Hepatic Steatosis ... Treatment With Peginterferon and Ribavirin in Cirrhotic Patients With HCV...
DOTS

HBV Genotypes, Precore and Core Promoter Variants in Asian Patients... Quality of Life in Hepatitis C... Do Young Hepatocellular Carcinoma Patients Have Worse Prognosis?... Prognostic Factors for Patients With Cirrhosis and Kidney Dysfunction...
DOTS

Treatment and Prognostic Factors in Patients With Hepatocellular Carcinoma ... Non-invasive Models for Predicting Histology in Patients With HBV... Distribution of HBV Genotypes Among Patients With Chronic Infection...
DOTS

Surveillance of HCC in Hepatitis C Virus Infection ... Distinguishing Nonalcoholic Steatohepatitis from Fatty Liver ... Consensus on Extra-hepatic Portal Vein Obstruction ... Hepatic Fibrosis in Liver Transplant Patients with HCV...
DOTS

Re-evaluation of Serum ALT Upper Normal Limit ... Novel Markers to Evaluate Progression from Cirrhosis to HCC... Liver Transplantation and Delivery in Fulminant Hepatic Failure...
DOTS

IL-10 Promoter Polymorphisms and HBeAg Seroconversion in CHB... Liver Fibrosis in Hereditary Hemochromatosis...
DOTS

Effects of Fatty Liver and Related Factors on HCV Therapy...
DOTS

Laparoscopic Findings in Patients With NASH... Cirrhosis-Related Complications - Time-Dependent Predictor...
DOTS

2005
DOTS
Therapeutic Implications of Hepatitis B Virus Genotypes ... Portal Hypertension: From Pathophysiology to Clinical Practice ...
DOTS

Budesonide in Previously Untreated Autoimmune Hepatitis... Mortality Predictors in LT Recipients With Recurrent HCV ...
DOTS

Preconditioning by Extracorporeal Liver Support ... Treatment of HCV Reinfection With IFN-alfa-2b and Ribavirin...
DOTS

Basal Core-Promoter Mutant of HBV and Liver Disease Progression... Short-Term Post Liver Transplant Survival After MELD...
DOTS

Proposal for a Histological Scoring and Grading System for NAFLD... TIPS in Refractory Ascites: A Meta-Analysis ...
DOTS

HCC - Survival and Clinical Characteristics ... Increasing Frequency of Gram-Positive Bacteria in SBP...
DOTS

2004
DOTS
Lamivudine Treatment for Acute Severe Hepatitis B: A Pilot Study... Quantitative Assessment of Fibrosis in Liver Biopsies ...
DOTS

Tumor Hemodynamics in Small Hepatocellular Carcinomas... Characteristics & Outcome of Patients W/Cirrhosis & Refractory ...
DOTS

Implications of Bile Duct Injury in Autoimmune Hepatitis... Gene Mutations as Risk Factors in Chronic Hepatitis C...
DOTS

Liver Fibrosis and Primary Biliary Cirrhosis... Tamoxifen: A Novel Treatment for Primary Biliary Cirrhosis?...
DOTS

Clinical, Biochemical and Imaging-Verified Regression... Hepatocellular Carcinomas <2 cm in Diameter ...
DOTS

Evolution of Hepatitis B Virus Precore/Basal Core Promoter Gene... Hemochromatosis (HFE) Gene Mutations and Hepatitis C Virus... Possible Contribution of Circulating Transforming Growth Factor... Liver Transplantation in the Era of Model for End-Stage Liver...
DOTS

2003
DOTS
Mutations in the NS5A and E2-PePHD Regions of Hepatitis C Virus... Low Daily Dosage of Interferon for 1 Year After HCV-Related... Cytokine Gene Polymorphisms and the Susceptibility to Liver... Synergistic Interaction Between Aflatoxin B1 and Hepatitis B...
DOTS

Gene Expression In HCV-Associated Hepatocellular Carcinoma ... Decreasing Incidence of Hepatocellular Carcinoma Among Children ... Expression of 8-Hydroxy-2'-Deoxyguanosine in Chronic Liver... Isolated Tuberculous Liver Abscesses With Multiple Hyperechoic...
DOTS

Effect of Iron Overload and Dietary Fat on Indices of Oxidative ... High Rate of Long-Term Virological Response After a 1-Year... Impact of High-Dose Interferon Induction and Ribavirin Therapy... Clinical Significance of Antibody Against Hepatitis B Virus C...
DOTS

Back to Top


Related Resources
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.